Cargando…
Treatment adherence during childhood in individuals with phenylketonuria: Early signs of treatment discontinuation
INTRODUCTION: Phenylketonuria (PKU) is an autosomal recessive disorder characterized by a deficiency in phenylalanine (Phe) hydroxylase activity. Early diagnosis and continuous treatment with a low Phe diet prevents severe neurological and cognitive impairment. AIMS: 1. Analyze how treatment adheren...
Autores principales: | García, María Ignacia, Araya, Gabriela, Coo, Soledad, Waisbren, Susan E., de la Parra, Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412103/ https://www.ncbi.nlm.nih.gov/pubmed/28491816 http://dx.doi.org/10.1016/j.ymgmr.2017.04.006 |
Ejemplares similares
-
Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness
por: Chen, Huey-Fen, et al.
Publicado: (2021) -
Cognitive functioning in mild hyperphenylalaninemia
por: de la Parra, Alicia, et al.
Publicado: (2015) -
Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients
por: Vieira, E., et al.
Publicado: (2017) -
Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria
por: Bilder, Deborah A., et al.
Publicado: (2021) -
The effects of tetrahydrobiopterin (BH(4)) treatment on brain function in individuals with phenylketonuria()
por: Christ, Shawn E., et al.
Publicado: (2013)